All Comments by

  1. Joseph Arboleda-Velasquez on Immunotherapy for Cerebral Small Vessel Disease?
  2. Gabrielle Leblanc on Immunotherapy for Cerebral Small Vessel Disease?
  3. Elena Galea on For Better and Worse, TDP-43 Controls Microglia’s Phagocytic Prowess
  4. Axel Montagne, Zhen Zhao and Berislav Zlokovic on Immunotherapy for Cerebral Small Vessel Disease?
  5. Walter Kukull on New Study Disputes Claim That Heartburn Meds Raise Dementia Risk
  6. Gael Nicolas and Anne Rovelet-Lecrux on Novel presenilin mutations within Moroccan patients with Early-Onset Alzheimer's Disease.
  7. Matteo Santoro and Gernot Riedel on Trigger Warning: α-Synuclein Sets Off T Cells in Parkinson’s
  8. Markus Zweckstetter on Tau Filaments from the Alzheimer’s Brain Revealed at Atomic Resolution
  9. Eckhard Mandelkow on Tau Filaments from the Alzheimer’s Brain Revealed at Atomic Resolution
  10. David Sanders on Tau Filaments from the Alzheimer’s Brain Revealed at Atomic Resolution
  11. Carol Brayne and Suvi Hokkanen on For Better and Worse, TDP-43 Controls Microglia’s Phagocytic Prowess
  12. Christos Proukakis on Could Genetic Mosaicism in Adult Neurons Precipitate Disease?
  13. Richard Caselli on APOE4 Subtly Alters Brain Network Activity With Age
  14. Amy Borenstein on Preventing Dementia: Getting Closer to Recommendations
  15. Steffen Rossner on New Alzheimer’s Drug Shows Safety, Hints of Efficacy in Phase 2